You are here
FDA Approves Generic Synthroid Tablets
Levothyroxine Sodium Tablets are the generic version of Abbott Laboratories' Synthroid(R) Tablets.
"We are very pleased with this product approval," stated Robert J. Coury, Mylan's Vice Chairman and CEO. "This approval represents a very important addition to our product portfolio and finally brings closure to some of the tactics used by others to delay legitimate generic approvals."
The product will be shipped immediately.
Source: Mylan Laboratories, Inc.